Navigation Links
Dr. Suresh Koneru Introduces Zeltiq Non-Invasive Procedure For Fat Reduction
Date:6/15/2010

Dr. Koneru (Advanced Concepts in Plastic Surgery) is first to bring this New “Cool” Approach to San Antonio and South Central Texas

(PRWEB) June 15, 2010 -- For those looking for a trimmer physique without the pain and recovery time of surgery, Dr. Suresh Koneru offers the Zeltiq™ Procedure, a new non-invasive body contouring procedure, at his practice - Advanced Concepts in Plastic Surgery of San Antonio, Texas. Gentle and effective, the Zeltiq Procedure uses an innovative method of precisely controlled cooling (Coolsculpting™) to help reduce unsightly fat bulges and pads that do not respond to diet and exercise.


Zeltiq is an advanced, non-invasive, cooling technology that targets and eliminates fat cells without painful needles or incisions. In just a few months, the Zeltiq Procedure reduces abdominal fat, love handles (flanks), or back fat without the pain and recovery time associated with needles, incisions and anaesthesia.

The science behind the Zeltiq Procedure is called Cryolipolysis, a break-through body sculpting technology developed by world-renowned dermatologists at Massachusetts General Hospital in Boston, MA, (an affiliate of Harvard Medical School). Their research showed that fat cells are naturally more vulnerable to the effects of cold than other surrounding tissues, and the Coolsculpting™ technique works painlessly and effectively on these problem areas.

Dr. Koneru explains that using advanced cooling to eliminate fat cells is much better than existing devices which utilize heat, sound waves or other mechanical techniques. The Zeltiq cooling technology is a more natural approach, inducing fat cells to undergo a process of natural, non-invasive removal which gradually reduces the thickness of the fat layer.

“What patients love about the Zeltiq procedure is that it’s a painless and relaxing way to get great results in a short amount of time without surgery. In just a few months of treatment using Zeltiq Coolsculpting™, my patients see noticeable results and a better, more natural looking physique,” said Dr. Koneru. “This is great news for anyone who is reluctant to undergo a surgical invasive procedure in order to improve their body shape and appearance.”

Dr. Koneru treats patients in San Antonio, Austin, Houston and other cities in Central and South Texas. The Zeltiq Procedure is comfortable for most patients, and no pain medication is required. While undergoing the procedure, most patients keep themselves occupied by reading, working on a laptop, listening to music, or just relaxing. Also, there is no recovery time after the Zeltiq Procedure and patients usually resume their normal activities the same day, including work and exercise.

For more information or to schedule a consultation, please call 210-499-5900 or visit www.DrKoneru.com.

About Dr. Koneru
Dr. Suresh Koneru is a Board Certified Plastic Surgeon who has been in private practice in San Antonio since 1996. He is fully trained in all aspects of modern plastic and reconstructive surgery, including cosmetic surgery of the face and body, breast surgery (including breast reconstruction, breast augmentation, breast lift, and breast reduction), suction-assisted lipectomy (liposuction), body contouring (tummy tuck, belt lipectomy, post massive weight loss surgery), and laser procedures.

Licensed in Texas, Dr. Koneru is Board Certified in Plastic Surgery. He has been named one of Texas Monthly’s SuperDoctors every year since 2007.

###

Read the full story at http://www.prweb.com/releases/2010/06/prweb4139214.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces
2. Tosoh Bioscience Introduces TSK-GEL SP-3PW (30), a Higher-Capacity Resin for the Purification of Insulin and Other Therapeutic Peptides and Small Proteins
3. ViroPharma Introduces New Reconstitution System for Cinryze™ (C1 Esterase Inhibitor [Human])
4. Microfluidics Introduces Revolutionary Bottom-up Technology as a Platform for Continuous Pharmaceutical Manufacturing
5. Haydon Kerk Motion Solutions, Inc. Introduces the New 20mm Stepper Motor Linear Actuator
6. Intensive Nutrition Introduces NutriYummies, Innovative Children's Chewable Multivitamin
7. Photometrics Introduces 64-Bit PVCAM Driver
8. QImaging Introduces 64-Bit QCam Driver
9. Netsmart Technologies Introduces Netsmart Customer Innovation Award to Recognize Outstanding Use of Technology to Impact Quality of Care
10. endpoint Introduces First Fully Configurable IRT System
11. Quest Diagnostics Introduces Molecular Blood Test for Aiding Colorectal Cancer Detection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences announced ... has been appointed as a Certified Service ... IsoFlux system will be used in Genetracer Biotech,s novel ... lung and colon cancer, with plans to move to ... is utilizing Fluxion,s IsoFlux System to isolate, recover, and ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... procedures can be safely completed in an ambulatory surgery center (ASC) with satisfactory ... procedures and previous two-year TDR studies. , Jake Lubinski, president of AxioMed, ...
(Date:2/24/2017)... SAN FRANCISCO , Feb. 24, 2017 ... that is developing a new category of therapeutics, announced ... trial of SB-030 in peripheral artery disease. The trial ... locally administered single-use therapeutic, in the reduction of restenosis ... reached this critical development milestone for SB-030," said ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
Breaking Biology News(10 mins):